Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study shows tofacitinib helps control psoriatic arthritis in daily life

NCT ID NCT04517669

Completed Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well the drug tofacitinib works for people with psoriatic arthritis in everyday medical practice. Over 12 months, researchers tracked 116 adults to see if the drug reduced disease activity and improved quality of life. The goal was to understand real-world effectiveness, not to test a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriatic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIATIC ARTHRITIS

Contacts and locations

Locations

  • AZ Sint-Jan

    Bruges, 8000, Belgium

  • Algemeen Stedelijk Ziekenhuis

    Aalst, 9300, Belgium

  • Barzilai Medical Center

    Ashkelon, Israel

  • Bnai Zion Medical Center

    Haifa, 31048, Israel

  • C.H. Universitario de Vigo- Hospital Meixoeiro

    Vigo, Galicia, 36200, Spain

  • CHR Orleans

    Orléans, 45067, France

  • CHU Besançon - Hôpital Jean Minjoz

    Besançon, 25000, France

  • CHU Clermont Ferrand - Hopital Gabriel Montpied

    Clermont-Ferrand, 63000, France

  • CHU Tours - Hôpital Trousseau

    Tours, 37044, France

  • Centre Hospitalier Jean Rougier

    Cahors, 46000, France

  • Chaim Sheba Medical Center

    Ramat Gan, 52621, Israel

  • Galilee Medical Center

    Nahariya, Israel

  • Hadassah Hebrew University Medical Center - Ein Kerem

    Jerusalem, 91120, Israel

  • Hadassah University Hospital - Ein Kerem

    Jerusalem, 246000, Israel

  • Hopital Pasteur

    Nice, 6001, France

  • Hopital Purpan

    Toulouse, 31059, France

  • Hospital Quironsalud Infanta Luisa

    Seville, 41010, Spain

  • Hospital Regional Universitario de Malaga

    Málaga, 29010, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, 33011, Spain

  • Hospital Universitario Puerta del Mar

    Cadiz, 11009, Spain

  • Hospital Universitario Reina Sofia

    Córdoba, 14004, Spain

  • Hospital Universitario San Cecilio

    Granada, 18012, Spain

  • Hospital Universitario Virgen Macarena

    Seville, 41009, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, 18014, Spain

  • Hospital de Especialidades de Jerez de la Frontera

    Cadiz, 11407, Spain

  • Infirmerie Protestante de Lyon

    Caluire-et-Cuire, 69300, France

  • Karolinska University Hospital, Solna

    Stockholm, Sweden

  • Lund University

    Lund, Sweden

  • Medisch Centrum Leeuwarden

    Leeuwarden, Netherlands

  • Medisch Spectrum Twente, Haaksbergerstraat

    Enschede, 7512 KZ, Netherlands

  • Norrlands University Hospital Umeå, Reumatologiska kliniken Västerbotten

    Umeå, Sweden

  • Nova Reuma Społka Partnerska

    Genk, 3600, Belgium

  • Rambam Health Care Center

    Haifa, Israel

  • Sheba Medical Center

    Ramat Gan, Israel

  • Skånes Universitetssjukhus, Malmö

    Malmö, Sweden

  • Soroka University Medical Center

    Beersheba, 84001, Israel

  • Sygehus Vendsyssel Hospital

    Hjørring, Denmark

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • The Baruch Padeh Medical Center - Poriya

    Tiberias, 15208, Israel

  • The Lady Davis Carmel Medical Center

    Haifa, 3436212, Israel

  • Turku University Hospital

    Turku, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.